12 mL of blood to be collected for RNA, DNA, and plasma

Intra Cerebral Hemorrhage

Subarachnoid Hemorrhage

Intraventricular Hemorrhage

Nontraumatic Haemorrhage

University of Maryland Medical Center

Recovery After Cerebral Hemorrhage

Recovery After Cerebral Hemorrhage--Improving Outcomes for Patients With Life-Threatening Neurologic Illness

The Barthel scale is an ordinal scale used to measure performance in activities of daily living. Scores range from 0 to 100. A higher score signifies better outcomes, more independent functionality.

The Montreal Cognitive Assessment was developed as a quick screening tool for neurological function. It assesses the domains of attention and concentration, executive function, memory, language, visuoconstructional skills, conceptual thinking, calculation, and orientation. The MoCA has been tested extensively for use in a variety of disorders affecting cognition such as HIV, Huntington's chorea, Multiple Sclerosis, Parkinson's disease, stroke, vascular dementia, and substance abuse in addition to the wellness of older adults. The MoCA has been tested in ages ranging from as young as 49 in two reports to old-old (85+) with a variety of education levels. The total possible score is 30 points with a score of 26 or more considered normal.

The Modified Rankin Scale (mRS) measures degree of disability/dependence after a stroke. Scores range from 0 to 6. A lower score signifies better outcomes, more independent functionality.

Medical history from hospital discharge to three months will help researchers learn of any adverse events or other medical complications.

EQ-5D is a standardised measure of health status developed by the EuroQol Group in order to provide a simple, generic measure of health for clinical and economic appraisal. The EQ-5D questionnaire also includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).

Gunjan Parikh

Assistant Professor

University of Maryland, Baltimore

Dexamethasone 0.6 mg/kg IV (max 15 mg) before departure from the ED.

The control group received a similar looking placebo (NaCl 0,9% IV) with the same volume.

Migraine

The intervention of interest was the administration of dexamethasone 0.6 mg/kg IV (max 15 mg) before departure from the ED. The control group received a similar looking placebo (NaCl 0,9% IV) with the same volume.

Dexamethasone group

Placebo group

CHU Sainte Justine

RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED

Randomised Controlled Trial of Intravenous Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Pediatric Emergency Department

by questionnaire (heartburns, constipation, personality changes such as irritability, and sleeping problem ad 7 days

Geneviève Tourigny-Ruel

Paediatric Emergency Physician

St. Justine's Hospital

All adolescent recipients of MenACYW-CRM vaccines during the study period. Among these, adolescents who have additionally experienced an event of interest within the 1-year observation period following vaccination will be included in the self-controlled case series.

Meningococcal Disease

MenACYW-CRM vaccination received as part of routine clinical care and as registered in the vaccine records.

MenACWY-CRM

Riverside Medical Center Campus, 10800 Magnolia Ave

San Diego Medical Center Campus, 4647 Zion Ave 92120

Fontana Medical Center Campus

Safety of MenACWY-CRM Vaccination in Adolescents

A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age

Novartis Vaccines

Novartis

Continuous infusion of rocuronium with 0,25mg/kg (blinded) for 29 hours after initiation of mild therapeutic hypothermia

Continuous infusion of sodium-chloride (placebo) and rocuronium bolus (0,25mg/kg)in case of shivering episode (blinded)

Cardiac Arrest With Successful Resuscitation

Hypothermia

Skeletal Muscle Relaxant Overdose

continuous application of rocuronium 0,25mg/kg/h (blinded), in case of shivering episode bolus sodium-chloride (blinded)

rocuronium

continuous infusion of sodium-chloride (blinded), in case of shivering episode application of rocuronium 0,25mg/kg (blinded)

placebo

Medical University of Vienna, Department of Emergency Medicine

Skeletal Muscle Paralysis in Hypothermic Patients After Cardiac Arrest

Requirement of Skeletal Muscle Paralysis in Hypothermic Patients After Cardiac Arrest - a Pilot Study

Shivering episodes will be detected according to the Shivering Assessment Scale

In case of a shivering episode, a bolus of rocuronium will be administered (0,25mg/kg)

myasthenia gravis/seizures

Recovery After Cerebral Hemorrhage

RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED

Safety of MenACWY-CRM Vaccination in Adolescents

Skeletal Muscle Paralysis in Hypothermic Patients After Cardiac Arrest

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu